Molecular Pharmacology (USA), Other Current Liabilities

Molecular Pharmacology (USA), (MLPH) currently reports a other current liabilities of $4.2M as of September 2014. That compares with $4.2M in the prior-year period — down 1.7% year over year. Use the charts on this page to explore Molecular Pharmacology (USA),'s other current liabilities history and peer comparisons.

Molecular Pharmacology (USA),'s other current liabilities decreased from $4.2M to $4.2M — a 1.7% year-over-year decrease (period ending September 2014). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Molecular Pharmacology (USA), reported $4.2M in other current liabilities as of September 2014. That compares with $4.2M in the prior-year period — down 1.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $4.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Molecular Pharmacology (USA),, and consider following MLPH for alerts when major investors trade the stock.